Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Farmers Insurance
UBS
Medtronic
Daiichi Sankyo
Deloitte
Harvard Business School
US Army
Teva

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,643,602

« Back to Dashboard

Summary for Patent: 5,643,602
Title: Oral composition for the treatment of inflammatory bowel disease
Abstract:An oral pharmaceutical composition is described for targeted slow release in the treatment of inflammatory bowel diseases. Also described are pharmaceutical compositions for peroral treatment targeted to different areas of the intestinal tract afflicted by ulcerative colitis and certain aspects of Crohn's disease.
Inventor(s): Ulmius; Jan (Lund, SE)
Assignee: Astra Aktiebolag (Sodertalje, SE)
Application Number:08/240,078
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form; Composition; Process;

Drugs Protected by US Patent 5,643,602

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,643,602

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8903914Nov 22, 1989

International Patents Family Members for US Patent 5,643,602

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Israel 96415 ➤ Try a Free Trial
Egypt 19642 ➤ Try a Free Trial
European Patent Office 0502092 ➤ Try a Free Trial
Spain 2074698 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
UBS
Argus Health
US Department of Justice
Merck
Fish and Richardson
Express Scripts
US Army
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.